24 research outputs found

    Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction

    Get PDF
    Diabetic nephropathy (DN) is a major cause of end-stage renal disease, and therapeutic options for preventing its progression are limited. To identify novel therapeutic strategies, we studied protective factors for DN using proteomics on glomeruli from individuals with extreme duration of diabetes (≥ 50 years) without DN and those with histologic signs of DN. Enzymes in the glycolytic, sorbitol, methylglyoxal and mitochondrial pathways were elevated in individuals without DN. In particular, pyruvate kinase M2 (PKM2) expression and activity were upregulated. Mechanistically, we showed that hyperglycemia and diabetes decreased PKM2 tetramer formation and activity by sulfenylation in mouse glomeruli and cultured podocytes. Pkm-knockdown immortalized mouse podocytes had higher levels of toxic glucose metabolites, mitochondrial dysfunction and apoptosis. Podocyte-specific Pkm2-knockout (KO) mice with diabetes developed worse albuminuria and glomerular pathology. Conversely, we found that pharmacological activation of PKM2 by a small-molecule PKM2 activator, TEPP-46, reversed hyperglycemia-induced elevation in toxic glucose metabolites and mitochondrial dysfunction, partially by increasing glycolytic flux and PGC-1α mRNA in cultured podocytes. In intervention studies using DBA2/J and Nos3 (eNos) KO mouse models of diabetes, TEPP-46 treatment reversed metabolic abnormalities, mitochondrial dysfunction and kidney pathology. Thus, PKM2 activation may protect against DN by increasing glucose metabolic flux, inhibiting the production of toxic glucose metabolites and inducing mitochondrial biogenesis to restore mitochondrial function

    Nutrition and Periodontal Health in the Patients with Diabetes Mellitus : a Review from the Viewpoint of Endothelial Function.

    No full text
    Purpose of Review:This review aims to summarize the literature on periodontal disease and nutrition, focusing on endothelialdysfunction in diabetic patients, and their impact on oral health.Recent Findings:Environmental factors, including smoking, obesity, and diabetes are well-known risk factors for the onset and progression of the periodontal disease. Indeed, dietary factors show an association with periodontal health through local and systemic environments. In addition, systemic factors, such as insulin resistance and diabetes, may have an important role in the periodontal health. Although molecular mechanisms underlying this are not fully understood, endothelial dysfunction mainly by hyperglycemia and/or chronic inflammation may explain the association between periodontal status and nutrition. In this paper, we reviewed recent progress in this field and propose the potential impact of nutritional intervention in the oral health from the viewpoint of endothelial function.Summary:It is expected to become increasingly important to understand the pathology of diabetes-related periodontal disease and consider nutritional approaches with vascular dysfunction in mind for its prevention and treatment. Further accumulation of evidence is anticipated for the future

    Glycemic control and number of natural teeth : analysis of cross-sectional Japanese employment-based dental insurance claims and medical check-up data.

    No full text
    Aim:Diabetes mellitus is a well-known risk factor for onset and progression of periodontal disease. However, the continuous relationship between glycemic control and the number of natural teeth has not been well characterized in large-scale studies. We aimed to determine whether the glycated hemoglobin A1c (HbA1c) level and fasting plasma glucose (FPG) are associated with the number of natural teeth.Methods:A cross-sectional study: A database comprising employment-based health insurance claim and medical check-up data from 706,150 participants between April 2015 and March 2016 in Japan. The exclusion criteria included missing data regarding dental receipts, number of natural teeth, HbA1c, smoking status, and age < 20 years. Ultimately, 233,567 individuals were analyzed. The participants were allocated to five groups according to their HbA1c and three groups according to their FPG, and then the number of natural teeth were compared.Results:Higher HbA1c was associated with fewer teeth in participants ≥ 30 years of age (P for trend < 0.001). Higher FPG was associated with fewer teeth between 30 and 69 years of age (P for trend < 0.001). Participants with impaired fasting glucose was already at risk for fewer teeth between 40 and 69 years of age than those with normal FPG.Conclusions:Glycemic control is strongly associated with the number of natural teeth in the real-world setting. Furthermore, there are continuous relationships of HbA1c and FPG with number of natural teeth including individual with impaired fasting glucose. These data emphasize the importance of glycemic control and appropriate oral care for the protection against tooth loss
    corecore